ARDT logo

Ardent Health Partners, LLC (ARDT) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

ARDT, 8.78$ (piyasa değeri 2B) fiyatla Healthcare işi olan Ardent Health Partners, LLC'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 54/100 puan alıyor.

Son analiz: 8 Şub 2026
54/100 AI Puanı Hedef $13.07 (+48.8%) PD 2B Hacim 243K

Ardent Health Partners, LLC (ARDT) Sağlık ve Boru Hattı Genel Bakışı

CEOMartin J. Bonick
Çalışanlar19200
MerkezBrentwood, TN, US
SektörHealthcare

Ardent Health Partners offers a notable research candidate within the healthcare sector, leveraging its established network of hospitals and clinics, strategic focus on diverse healthcare services, and a current P/E ratio of 6.13, positioning it for potential growth and value creation.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 8 Şub 2026

Yatırım Tezi

Ardent Health Partners presents a notable research candidate due to its established network of hospitals and clinics, coupled with a focus on diverse healthcare services. With a current P/E ratio of 6.13 and a profit margin of 3.2%, Ardent demonstrates potential for value creation. Key growth catalysts include expanding its network of facilities and enhancing service offerings to capture a larger share of the healthcare market. The company's strong gross margin of 70.6% indicates efficient operations and pricing power. Furthermore, Ardent's beta of 0.71 suggests lower volatility compared to the broader market, making it a noteworthy option for risk-averse investors. The increasing demand for healthcare services, driven by an aging population and advancements in medical technology, provides a favorable backdrop for Ardent's continued growth and profitability. Investors may want to evaluate Ardent for its stability, growth potential, and attractive valuation metrics.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $1.28 billion reflects Ardent's significant presence in the healthcare market.
  • P/E ratio of 6.13 indicates a potentially undervalued stock compared to its earnings.
  • Profit margin of 3.2% demonstrates the company's ability to generate profit from its revenue.
  • Gross margin of 70.6% highlights efficient cost management and strong pricing power.
  • Beta of 0.71 suggests lower volatility compared to the overall market, making it a relatively stable investment.

Rakipler & Benzerleri

Güçlü Yönler

  • Established network of hospitals and clinics.
  • Comprehensive range of healthcare services.
  • Strong gross margin of 70.6%.
  • Experienced management team.

Zayıflıklar

  • Reliance on third-party payers (insurance companies).
  • Exposure to regulatory changes in the healthcare industry.
  • Potential for increased competition in certain markets.
  • Subsidiary status might limit strategic flexibility.

Katalizörler

  • Ongoing: Expansion of service offerings to include more specialized medical programs.
  • Upcoming: Potential acquisitions of smaller healthcare providers to expand market reach.
  • Ongoing: Implementation of technology solutions to improve patient care and operational efficiency.
  • Ongoing: Strategic partnerships with insurance companies to enhance patient access.

Riskler

  • Potential: Changes in government healthcare policy could negatively impact reimbursement rates.
  • Ongoing: Rising operating costs, including labor and supplies, could erode profit margins.
  • Ongoing: Increased competition from other healthcare providers could lead to pricing pressure.
  • Potential: Medical malpractice claims could result in significant financial liabilities.
  • Potential: Economic downturn could reduce patient volumes and revenue.

Büyüme Fırsatları

  • Expanding Network of Facilities: Ardent has the opportunity to grow by acquiring or developing new hospitals and clinics in underserved markets. The U.S. healthcare market is projected to reach $6.2 trillion by 2028, providing ample opportunity for expansion. By strategically targeting areas with growing populations and limited access to healthcare services, Ardent can increase its market share and revenue. This expansion could be achieved through strategic partnerships or acquisitions, with a timeline of 3-5 years.
  • Enhancing Service Offerings: Ardent can enhance its service offerings by investing in specialized medical programs, such as cardiology, oncology, and orthopedics. The market for specialized medical services is growing rapidly, driven by advancements in medical technology and increasing demand from patients. By offering a wider range of specialized services, Ardent can attract more patients and increase its revenue per patient. This enhancement can be implemented within 2-3 years.
  • Improving Operational Efficiency: Ardent can improve its operational efficiency by implementing lean management principles and investing in technology to streamline processes and reduce costs. The healthcare industry is facing increasing pressure to reduce costs while maintaining quality of care. By improving operational efficiency, Ardent can increase its profit margins and remain competitive. This improvement can be achieved through process optimization and technology adoption within 1-2 years.
  • Leveraging Technology: Ardent can leverage technology to improve patient care, enhance operational efficiency, and expand its reach. Telemedicine, remote patient monitoring, and data analytics are transforming the healthcare industry, offering new opportunities for providers to deliver care more efficiently and effectively. By embracing these technologies, Ardent can improve patient outcomes, reduce costs, and gain a competitive advantage. Implementation can start immediately and scale over 2-5 years.
  • Strategic Partnerships: Ardent can form strategic partnerships with other healthcare providers, insurance companies, and technology companies to expand its reach and enhance its service offerings. Collaboration is becoming increasingly important in the healthcare industry, as providers seek to deliver more integrated and coordinated care. By forming strategic partnerships, Ardent can access new markets, technologies, and expertise, driving growth and innovation. These partnerships can be established within 1-3 years.

Fırsatlar

  • Expansion into new geographic markets.
  • Acquisition of smaller healthcare providers.
  • Development of new specialized medical programs.
  • Leveraging technology to improve patient care and efficiency.

Tehditler

  • Changes in government healthcare policy.
  • Rising operating costs (labor, supplies).
  • Increased competition from other healthcare providers.
  • Potential for medical malpractice claims.

Rekabet Avantajları

  • Established network of hospitals and clinics provides a geographic advantage.
  • Strong relationships with insurance providers ensure a steady stream of patients.
  • Reputation for quality care attracts patients and physicians.
  • Economies of scale in purchasing and operations reduce costs.

ARDT Hakkında

Founded in 2001 and headquartered in Brentwood, Tennessee, Ardent Health Partners, LLC has established itself as a significant player in the healthcare industry. The company owns and operates a network of hospitals and clinics throughout the United States, providing a comprehensive suite of healthcare services. These services encompass acute care, rehabilitation hospitals, and surgical hospitals, catering to a diverse range of patient needs. Ardent's commitment to quality care and operational efficiency has enabled it to build a strong reputation within the communities it serves. As a subsidiary of EGI-AM Investments, L.L.C., Ardent benefits from strategic guidance and financial support, fostering continued growth and expansion. The company's network is designed to offer accessible and integrated healthcare, ensuring patients receive the right care at the right time. Ardent's focus on patient-centered care, combined with its strategic investments in technology and infrastructure, positions it favorably in the evolving healthcare landscape. The company's dedication to providing a continuum of care, from acute interventions to rehabilitative services, underscores its commitment to improving patient outcomes and enhancing the overall healthcare experience.

Ne Yaparlar

  • Operates a network of acute care hospitals.
  • Provides rehabilitation hospital services.
  • Offers surgical hospital services.
  • Manages a network of clinics.
  • Delivers a range of healthcare services in the United States.
  • Focuses on patient-centered care.
  • Provides integrated healthcare solutions.

İş Modeli

  • Generates revenue through patient services at hospitals and clinics.
  • Receives payments from insurance companies, government programs (Medicare/Medicaid), and self-paying patients.
  • Focuses on managing costs and improving operational efficiency to maximize profitability.

Sektör Bağlamı

Ardent Health Partners operates within the medical care facilities industry, a sector experiencing steady growth driven by an aging population and increasing demand for healthcare services. The industry is characterized by a mix of large hospital systems and smaller, specialized clinics. Ardent competes with other for-profit and non-profit healthcare providers, including ACHC, ADUS, ASTH, AVAH, and BKD. The market is also influenced by regulatory changes, technological advancements, and evolving patient preferences. Companies that can adapt to these changes and deliver high-quality, cost-effective care are well-positioned for success. Ardent's focus on integrated healthcare services and strategic expansion efforts align with these industry trends.

Kilit Müşteriler

  • Individuals seeking acute care services.
  • Patients requiring rehabilitation services.
  • Individuals in need of surgical procedures.
  • Patients seeking general medical care at clinics.
AI Güveni: 72% Güncellendi: 8 Şub 2026

Finansallar

Grafik & Bilgi

Ardent Health Partners, LLC (ARDT) hisse senedi fiyatı: $8.78 (+0.30, +3.47%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

ARDT için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

Konsensüs hedefi: $13.07

MoonshotScore

54/100

Bu puan ne anlama geliyor?

MoonshotScore, ARDT'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

En Son Ardent Health Partners, LLC Analizi

Yatırımcılar Ardent Health Partners, LLC (ARDT) Hakkında Ne Soruyor

ARDT için değerlendirilmesi gereken temel faktörler nelerdir?

Ardent Health Partners, LLC (ARDT) şu anda yapay zeka skoru 54/100, orta puanı gösteriyor. Hisse 7.3x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) altında, potansiyel değer sinyali. Analist hedefi $13.07 ($8.78'dan +49%). Temel güçlü yan: Established network of hospitals and clinics.. İzlenmesi gereken birincil risk: Potential: Changes in government healthcare policy could negatively impact reimbursement rates.. Bu bir finansal tavsiye değildir.

ARDT MoonshotScore'u nedir?

ARDT şu anda MoonshotScore'da 54/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

ARDT verileri ne sıklıkla güncellenir?

ARDT fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler ARDT hakkında ne diyor?

Analistler, ARDT için $13.07 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($8.78) yukarı yönlü %49 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.

ARDT'a yatırım yapmanın riskleri nelerdir?

ARDT için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changes in government healthcare policy could negatively impact reimbursement rates.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

ARDT'ın P/E oranı nedir?

Ardent Health Partners, LLC (ARDT)'nın son P/E oranı 7.3, ki bu da piyasa ortalamasının altında, bu da göreli değeri gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.

ARDT aşırı değerli mi, yoksa düşük değerli mi?

Ardent Health Partners, LLC (ARDT)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 7.3. Analist hedefi $13.07 (mevcut fiyattan +49%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

ARDT'ın temettü verimi nedir?

Ardent Health Partners, LLC (ARDT) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is based on available information and may be subject to change.
  • Industry analysis is based on current market trends and may not reflect future developments.
  • Investment decisions should be made based on individual circumstances and consultation with a financial advisor.
Veri Kaynakları

Popüler Hisseler